Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes.
Büscheck F, Fraune C, Simon R, Kluth M, Hube-Magg C, Möller-Koop C, Sarper I, Ketterer K, Henke T, Eichelberg C, Dahlem R, Wilczak W, Sauter G, Fisch M, Eichenauer T, Rink M.
Büscheck F, et al. Among authors: dahlem r.
Oncotarget. 2020 Jan 21;11(3):237-249. doi: 10.18632/oncotarget.27428. eCollection 2020 Jan 21.
Oncotarget. 2020.
PMID: 32076485
Free PMC article.